| Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19. ARCAPI ATTACC New England Journal of Medicine 385 (9), 790-802, 2021 | 945 | 2021 |
| REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19. T Investigators. NEJM 385 (23), e81, 2021 | 555* | 2021 |
| Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial MN Kosiborod, R Esterline, RHM Furtado, J Oscarsson, SB Gasparyan, ... The lancet Diabetes & endocrinology 9 (9), 586-594, 2021 | 170 | 2021 |
| Subclinical hypothyroidism SKY Gosi, VV Garla | 167 | 2019 |
| Fracture healing overview JR Sheen, A Mabrouk, VV Garla StatPearls [Internet], 2023 | 99 | 2023 |
| Therapeutic anticoagulation with heparin in critically ill patients with COVID-19 REMAP-CAP, ACTIV-4a, and ATTACC Investigators New England Journal of Medicine 385 (9), 777-789, 2021 | 51* | 2021 |
| Incidence and mortality of acute kidney injury in patients undergoing hematopoietic stem cell transplantation: a systematic review and meta-analysis SR Kanduri, W Cheungpasitporn, C Thongprayoon, T Bathini, K Kovvuru, ... QJM: An International Journal of Medicine 113 (9), 621-632, 2020 | 38 | 2020 |
| Maternal and fetal outcomes in phaeochromocytoma and pregnancy: a multicentre retrospective cohort study and systematic review of literature I Bancos, E Atkinson, C Eng, WF Young, HPH Neumann, M Yukina, ... The Lancet Diabetes & Endocrinology 9 (1), 13-21, 2021 | 33 | 2021 |
| Non-islet cell hypoglycemia: case series and review of the literature V Garla, H Sonani, V Palabindala, C Gomez-Sanchez, J Subauste, ... Frontiers in Endocrinology 10, 316, 2019 | 33 | 2019 |
| Management of diabetes mellitus in chronic kidney disease: an overview. LLF Garla VV, Kanduri S, Yanes-Cardozo L Minerva Endocrinol., 2019 | 26* | 2019 |
| Osteoporosis in males. StatPearls. Treasure island (FL): StatPearls Publishing Copyright© 2021 MO Bello, LRS Sombra, C Anastasopoulou, VV Garla StatPearls Publishing LLC., 2021 | 24 | 2021 |
| Off-label use and misuse of testosterone, growth hormone, thyroid hormone, and adrenal supplements: risks and costs of a growing problem MS Irwig, M Fleseriu, J Jonklaas, NA Tritos, KCJ Yuen, R Correa, ... Endocrine Practice 26 (3), 340-353, 2020 | 24 | 2020 |
| Severe hyperthyroidism complicated by agranulocytosis treated with therapeutic plasma exchange: case report and review of the literature V Garla, K Kovvuru, S Ahuja, V Palabindala, B Malhotra, S Abdul Salim Case Reports in Endocrinology 2018, 2018 | 24 | 2018 |
| Risk factors and management of osteoporosis post-transplant K Kovvuru, SR Kanduri, P Vaitla, R Marathi, S Gosi, DFG Anton, ... Medicina 56 (6), 302, 2020 | 21 | 2020 |
| Somatostatin receptor expression in non-classical locations–clinical relevance? E Bhanat, CA Koch, R Parmar, V Garla, V Vijayakumar Reviews in Endocrine and Metabolic Disorders 19, 123-132, 2018 | 20 | 2018 |
| Thyrotoxic periodic paralysis: case report and review of the literature VV Garla, M Gunturu, KR Kovvuru, SA Salim Electronic physician 10 (8), 7174, 2018 | 19 | 2018 |
| Adrenal myelolipoma MR Bokhari, H Zulfiqar, VV Garla | 19 | 2017 |
| SGLT2 inhibitors and kidney outcomes in patients with chronic kidney disease SR Kanduri, K Kovvuru, P Hansrivijit, C Thongprayoon, S Vallabhajosyula, ... Journal of Clinical Medicine 9 (9), 2723, 2020 | 18 | 2020 |
| Current therapeutic approaches in the management of hyperglycemia in chronic renal disease V Garla, L Yanes-Cardozo, LF Lien Reviews in Endocrine and Metabolic Disorders 18, 5-19, 2017 | 17 | 2017 |
| Polyglandular autoimmune syndrome type I MO Bello, VV Garla | 15 | 2019 |
